Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma
HemaSphere · 2026-06 · 10 (6)
DOI: 10.1002/hem3.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift HemaSphere, online erschienen am 22.06.2026. Verfasst von Julia C Kuehn und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biological mechanisms underlying clinical heterogeneity in central nervous system lymphoma (CNSL) are largely unknown. While previous studies suggest the chemokine CLL19 as a crucial factor for the formation of CNSL in murine models, its role in human disease remains elusive. Here, we performed in‐depth genetic and transcriptomic profiling of 82 CNSL specimens and identified distinct genetic aberrations and tumor cell compositions in lymphomas with high CCL19 expression, both of which were associated with immunosuppressive and anti‐apoptotic signatures. CCL19 levels varied widely across CNSL patients. High CCL19 expression was significantly and independently associated with inferior progression‐free and overall survival. Spatial and single‐nucleus analyses as well as immunohistochemistry revealed pericytes within vessel‐rich areas as the predominant source of CCL19, accompanied by significant co‐localization of CCL19 with its primary receptor CCR7 that was enriched in plasmablast‐like malignant B cells, as well as dendritic cells, NK cells, and CD4 + T cells. Collectively, our study identified pericyte‐derived CCL19 as a novel prognostic marker in CNSL that is associated with unfavorable genetic aberrations and modifications of the immune landscape towards a resting tumor microenvironment. Spatial CCR7 co‐localization suggests avenues for future therapeutic strategies targeting the CCL19–CCR7 axis.
Autor:innen und Institutionen
- Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany.
- Institute of Neuropathology, Faculty of Medicine University of Freiburg Freiburg Germany.
- German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ) Heidelberg Germany.
- Department of Medicine, Divisions of Oncology and Hematology Stanford University Stanford California USA.
- Department of Neurosurgery, Medical Center - University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany.
- Department of Neurosurgery, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg Erlangen Germany.
ORCID-Profile: Julia C Kuehn
Zitieren
APA
Kuehn, J. C., Miarka, L., Sankowski, R., Mutter, J., Neidert, N. N., Grabis, E., Zhang, J., Klingler, C., Hummel, F., Ranganathan, L., Bleul, S., Lauer, E. M., Heiland, D. H., Müller, K., Reinhardt, H. C., Dietrich, S., Illerhaus, G., von Baumgarten, L., Alig, S., …, & Scherer, F. (2026). Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma. HemaSphere, 10(6). https://doi.org/10.1002/hem3.70412
Vancouver
Kuehn JC, Miarka L, Sankowski R, Mutter J, Neidert NN, Grabis E, et al. Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma. HemaSphere. 2026;10(6). doi:10.1002/hem3.70412
BibTeX
@article{Kuehn2026,
author = {Kuehn, Julia C and Miarka, Lauritz and Sankowski, Roman and Mutter, Jurik and Neidert, Nicolas N and Grabis, Elena and Zhang, Junyi and Klingler, Christian and Hummel, Fabian and Ranganathan, Lavanya and Bleul, Sabine and Lauer, Eliza M and Heiland, Dieter H and Müller, Katharina and Reinhardt, Hans C and Dietrich, Sascha and Illerhaus, Gerald and von Baumgarten, Louisa and Alig, Stefan and Diehn, Maximilian and Sajonz, Bastian E A and Beck, Jürgen and Coenen, Volker A and Prinz, Marco and Schorb, Elisabeth and Alizadeh, Ash A and Duyster, Justus and Reinacher, Peter and Scherer, Florian},
title = {Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {6},
doi = {10.1002/hem3.70412}
}
EUVIMED